L. Martin

发表

Inhibition of Nonsense-Mediated RNA Decay Activates Autophagy

H. Dietz, Jordan Wengrod, Lawrence B. Gardner, 2013, Molecular and Cellular Biology.

The bcl-3 Proto-Oncogene Encodes a Nuclear IidB-Like Molecule That Preferentially Interacts with NF-KB p50 and p52 in a Phosphorylation-Dependent Manner

G. Nolan, H. Liou, Scott, 2003 .

Decay Activates Autophagy Inhibition of Nonsense-Mediated RNA

H. Dietz, Jordan Wengrod, Ding Wang, 2013 .

Inhibition of Nonsense-Mediated RNA Decay by the Tumor Microenvironment Promotes Tumorigenesis

J. Zavadil, D. Levy, F. Parisi, 2011, Molecular and Cellular Biology.

Stress-induced inhibition of nonsense mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11

Lawrence B. Gardner, Leenus Martin, L. Martin, 2014, Oncogene.

Identi ﬁ cation and Characterization of Small Molecules That Inhibit Nonsense-Mediated RNA Decay and Suppress Nonsense p53 Mutations

S. Rivella, T. Cardozo, Lawrence B. Gardner, 2022 .

Antitumor Activity of RXDX-105 in Multiple Cancer Types with RET Rearrangements or Mutations

M. Ladanyi, A. Drilon, Shunqi Yan, 2016, Clinical Cancer Research.

Regulation of the Unfolded Protein Response by eIF2Bδ Isoforms*

S. Kimball, Lawrence B. Gardner, Leenus Martin, 2010, The Journal of Biological Chemistry.

The replicon initiation burst released by reoxygenation of hypoxic T24 cells is accompanied by changes of MCM2 and Cdc7.

L. Martin, 2007, Journal of biochemistry and molecular biology.

Hypoxic activation of ATR and the suppression of the initiation of DNA replication through cdc6 degradation

C. Santocanale, Lawrence B. Gardner, M. Rainey, 2011, Oncogene.

Abstract 1943: PARG inhibitors exhibit synthetic lethality with XRCC1 deficiency and a cellular mechanism of action that is distinct from PARP inhibition

Kedar S Vaidya, M. P. Dillon, M. Fischer, 2018, Experimental and Molecular Therapeutics.

PD184352 releases the regular hypoxic reversible DNA replication arrest in T24 cells.

L. Martin, 2007, Journal of biochemistry and molecular biology.

Abstract 2670: ERAS-601, a potent allosteric inhibitor of SHP2, synergistically enhances the efficacy of sotorasib/adagrasib and cetuximab in NSCLC, CRC, and HNSCC tumor models

L. Brail, Taylor Congdon, Roopal V Patel, 2022, Cancer Research.